Follow
Arka Das
Arka Das
PhD Scholar, SRF, National Institute of Pharmaceutical Education and Research, Kolkata
Verified email at niperkolkata.ac.in
Title
Cited by
Cited by
Year
Molecular docking and molecular dynamic studies: screening of phytochemicals against EGFR, HER2, estrogen and NF-KB receptors for their potential use in breast cancer
GS Purawarga Matada, PS Dhiwar, N Abbas, E Singh, A Ghara, A Das, ...
Journal of Biomolecular Structure and Dynamics 40 (13), 6183-6192, 2022
222022
Management of COVID-19-induced cytokine storm by Keap1-Nrf2 system: a r eview
E Singh, GSP Matada, N Abbas, PS Dhiwar, A Ghara, A Das
Inflammopharmacology 29 (5), 1347-1355, 2021
222021
DDR1 and DDR2: a review on signaling pathway and small molecule inhibitors as an anticancer agent
GSP Matada, A Das, PS Dhiwar, A Ghara
Medicinal Chemistry Research 30 (3), 535-551, 2021
222021
Discovery of potential Aurora-A kinase inhibitors by 3D QSAR pharmacophore modeling, virtual screening, docking, and MD simulation studies
G Swamy PM, N Abbas, PS Dhiwar, E Singh, A Ghara, A Das
Journal of Biomolecular Structure and Dynamics 41 (1), 125-146, 2023
72023
Molecular recognition of some novel mTOR kinase inhibitors to develop anticancer leads by drug-likeness, molecular docking and molecular dynamics based virtual screening strategy
A Das, GSP Matada, PS Dhiwar, NM Raghavendra, N Abbas, E Singh, ...
Computational Toxicology 25, 100257, 2023
32023
Regioselective Decarboxylative Transformations of Tetrahydro-β-carboline-1-carboxylic Acid: Reagent Controlled Selectivity toward Alkynylated or Enaminone Products
A Das, C Jonathan, R Saha, MI Ahmed, S Bhowmik
Organic Letters 25 (40), 7310-7315, 2023
12023
Virtual screening of few novel Sulindac derivatives as multi-targeted agents
A Das, S Nandi, K Das, S Banerjee
Drug Discov 14 (33), 33-43, 2020
12020
Reprofiling the Antidiabetic Drugs to Restrict SARS-CoV-2: An In-Silico Approach
A Barik, A Das, P Sasmal
Drug Discovery 58 (321), 953-956, 2022
2022
Design and discovery of some novel protease inhibitors against SARS-CoV-2 main protease by molecular docking, drug-likeness and ADME studies: An in-silico approach
A Das, S Banerjee, KK Sen
International Pharmacy Acta 4 (1), 4e9: 1-13, 2021
2021
Design, synthesis, and evaluation of 1, 4-benzothiazine-3-one containing bis-amide derivatives as dual inhibitors of Staphylococcus aureus with plausible application in urinary …
K Naithani, A Das, M Ushare, S Nath, R Biswas, A Kundu, KT Ahmed, ...
Frontiers in Chemistry 12, 1420593, 0
The system can't perform the operation now. Try again later.
Articles 1–10